利舒康胶囊对慢性缺血缺氧症侯群的疗效探讨  

Observation on Curative Effect of Li Shu Kang Capsule on Chronic Ischemia and Hypoxia Symptom Grouping

作　　者：刘聪[1] 李俊青[1] 王驰仲[1] 李松[2] 孙淑贤[3] 屈宝华[1] 

机构地区：[1]安阳地区医院神经内科,河南安阳455000 [2]新乡医学院,河南新乡453003 [3]北京航天中心医院,北京100049

出　　处：《中外医疗》2016年第11期126-127,160,共3页China & Foreign Medical Treatment

摘　　要：目的探讨利舒康胶囊对慢性缺血缺氧症侯群的疗效。方法方便选择该院2014年6月—2015年12月门诊的200例慢性缺血缺氧症侯群患者(包括:阻塞性睡眠呼吸暂停综合症、慢阻肺伴脑梗塞、慢阻肺伴自主神经功能紊乱、一氧化碳中毒迟发脑病),将患者随机分为观察组和对照组,每组100例。对照组给予常规药物治疗,观察组在对照组治疗的基础上加利舒康胶囊,2周后借助辅助相关检查进行评分,观察4组患者临床症状改善情况。结果观察组总有效率79.00%,明显高于对照组24.00%。结论利舒康胶囊可以明显改善慢性缺血缺氧症侯群。Objective To observe the curative effect of Li Shu Kang Capsule on chronic ischemia and hypoxia symptom grouping. Methods 200 cases of patients with chronic ischemia and hypoxia symptom grouping treated in clinics of our hos- pital from June 2014 to December 2015 were selected （including： obstructive sleep apnea, ohronic obstructive pulmonary disease with cerebral infarction, chronic obstructive pulmonary disease with？autonomic nervous system？,？chronic en- cephalopathy of carbon monoxide poisoning）, and were divided into two groups with 100 cases in each, the control group were treated with conventional drugs, the observation group were treated with additional Li Shu Kcmg capsule on the basis of the control group, and both groups were scored by the auxiliary correlated examination after 2 weeks, and the clinical symp- toms and improvement of the four groups were observed. Results The total effective rate in the observation group was obvi- ously higher than that in the control group, （79.00% vs 24.00%）. Conclusion Li Shu Kang capsule can obviously improve the chronic ischemia and hypoxia symptom grouping.

关 键 词：利舒康胶囊 阻塞性睡眠呼吸暂停综合症 慢阻肺伴脑梗塞 慢阻肺伴自主神经功能紊乱 一氧化碳中毒迟发脑病 

分 类 号：R74[医药卫生—神经病学与精神病学]